References
Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T (1993) Frequent presence of anti-GQ1b antibody in Fisher’s syndrome. Neurology 43(2):414–417
Lee SU, Kim HJ, Choi JY, Kim JK, Kim JS (2019) Acute vestibular syndrome associated with anti-GQ1b antibody. Neurology 93(11):e1085–e1092
Lee EJ, Lim YM, Kim S, Choi L, Kim H, Kim K et al (2020) Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases. Ann Clin Transl Neurosci 7(6):992–1001
Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R et al (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 15(6):329–342
Trobe JD (2011) Papilledema: the vexing issues. J Neuroophthalmol 31(2):175–186
Suh SY, Kim SJ (2013) IIH with normal CSF pressures? Indian J Ophthalmol 61(11):681–682
Green JP, Newman NJ, Stow ZN, Nemeroff CB (1996) “Normal pressure” pseudotumor cerebri. J Neuroophthalmol 16(4):241–246
Miller NR, Newman NJ, Biousse V, Kerrison JB (2005) Walsh and Hoyt’s clinical neuro-ophthalmology, 6th edn. Lippincott Williams and Wilkins, Philadelphia
Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I (1997) Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 745(1):32–36
Chan J (2003) Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br J Ophthalmol 87(9):1185–1186
Mewasingh LD, Sekhara T, Dachy B, Djeunang MC, Dan B (2002) Benign intracranial hypertension: atypical presentation of Miller Fisher syndrome? Pediatr Neurol 26(3):228–230
Colding-Jørgensen E, Vissing J (2001) Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand 103(4):259–260
Biotti D, Boucher S, Ong E, Tilikete C, Vighetto A (2013) Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome. J Neurol 260(11):2890–2891
Yeak J, Zahari M, Sing S, Mohamad NF (2019) Co-occurrence of acute ophthalmoplegia (without ataxia) and idiopathic intracranial hypertension. Eur J Ophthalmol 29(4):NP1–NP4
Acknowledgements
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (No. NRF-2016R1D1A1B04935568).
Author information
Authors and Affiliations
Contributions
S-HK analyzed and interpreted the data and wrote the manuscript. S-HB, SY, and J-SK analyzed and interpreted the data, and revised the manuscript. S-UL designed and conceptualized the study, interpreted the data, and revised the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
Drs. S. H. Kim, Baek, Lee, and Yu report no disclosures. Dr. J. S. Kim serves as an associate editor of Frontiers in Neuro-otology and on the editorial boards of the Journal of Clinical Neurology, Frontiers in Neuro-ophthalmology, Journal of Neuro-ophthalmology, Journal of Vestibular Research, Journal of Neurology, Medicine, and Clinical Translational Neuroscience.
Ethical standards
This study followed the tenets of the Declaration of Helsinki and was performed according to the guidelines of Institutional Review Board of Korea University Anam Hospital (2021AN0081).
Rights and permissions
About this article
Cite this article
Kim, SH., Baek, SH., Lee, SU. et al. Optic disc edema as a sole manifestation of anti-GQ1b antibody syndrome. J Neurol 268, 2263–2266 (2021). https://doi.org/10.1007/s00415-021-10518-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10518-5